Amedisys, Inc. (AMED)

NASDAQ: AMED · IEX Real-Time Price · USD
93.14
-1.05 (-1.11%)
Feb 27, 2024, 4:00 PM EST - Market closed
-1.11%
Market Cap 3.08B
Revenue (ttm) 2.24B
Net Income (ttm) -9.75M
Shares Out 32.67M
EPS (ttm) -0.30
PE Ratio n/a
Forward PE 20.13
Dividend n/a
Ex-Dividend Date n/a
Volume 741,000
Open 94.04
Previous Close 94.19
Day's Range 90.66 - 94.55
52-Week Range 69.36 - 96.44
Beta 0.87
Analysts Hold
Price Target 99.43 (+6.75%)
Earnings Date Feb 21, 2024

About AMED

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and ai... [Read more]

Sector Healthcare
Founded 1982
Employees 19,000
Stock Exchange NASDAQ
Ticker Symbol AMED
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 8 analysts, the average rating for AMED stock is "Hold." The 12-month stock price forecast is $99.43, which is an increase of 6.75% from the latest price.

Price Target
$99.43
(6.75% upside)
Analyst Consensus: Hold
Stock Forecasts

News

Amedisys Reports Fourth Quarter and Year-End 2023 Financial Results

BATON ROUGE, La., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period and year ended December 31, 2023.

6 days ago - GlobeNewsWire

Amedisys Offers Molecular Testing for Rapid and Accurate Infection Diagnosis

BATON ROUGE, La., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care in the home, is now offering advanced molecular testi...

19 days ago - GlobeNewsWire

Amedisys Reports Third Quarter 2023 Financial Results

BATON ROUGE, La., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and nine-month periods ended September 30, 2023.

4 months ago - GlobeNewsWire

Amedisys Celebrates National Quality Week

Held October 15-21, this Observance Shines a Light on Our Commitment to Quality Care Held October 15-21, this Observance Shines a Light on Our Commitment to Quality Care

4 months ago - GlobeNewsWire

Amedisys Recognizes Suicide Prevention Awareness Month and Promotes the 988 Suicide & Crisis Lifeline

BATON ROUGE, La., Aug. 31, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care in the home, is proud to recognize September as Suici...

6 months ago - GlobeNewsWire

Amedisys Reports Second Quarter 2023 Financial Results

BATON ROUGE, La., July 26, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and six-month periods ended June 30, 2023.

7 months ago - GlobeNewsWire

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into the Fairness of the Acquisition of Amedisys, Inc. by Option Care Health, Inc.

NEW YORK , June 29, 2023 /PRNewswire/ --  The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Amedisys, Inc. (" Amedisys" or the "Company") (NAS...

8 months ago - PRNewsWire

UnitedHealth's Amedisys Deal Come as Home Health and Data Cement Care Ecosystems

In healthcare, the latest acquisition brings to mind that old Fred Astaire song lyric: “Won't you change partners and dance with me?” On Monday, as had been reported here, Amedisys, the home health an...

Other symbols: UNH
8 months ago - PYMNTS

UnitedHealth Buys Amedisys for $3.3 Billion

UnitedHealth Group outbid Option Care's offer to buy home healthcare provider Amedisys.

Other symbols: UNH
8 months ago - Investopedia

Amedisys Agrees to UnitedHealth Takeover, Scraps Option Care Health Merger

The unsolicited offer from UnitedHealth outbid a $2.8 billion deal.

Other symbols: UNH
8 months ago - WSJ

Amedisys Agrees to $3.3 Billion UnitedHealth Merger

Home health company Amedisys has agreed to a $3.3 billion merger with UnitedHealth Group. The deal calls for the acquisition of Amedisys' outstanding common stock in an all-cash transaction for $101 p...

Other symbols: UNH
8 months ago - PYMNTS

AMED Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Amedisys, Inc. Is Fair to Shareholders

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Amedisys, Inc. (NASDAQ: AMED) to Optum for $101.00 per share is fair to Amedisys sharehol...

8 months ago - Business Wire

UnitedHealth Agrees All-Cash Deal to Buy Amedisys

The move for the healthcare-service provider is worth $101 a share.

Other symbols: UNH
8 months ago - Barrons

Amedisys agrees to UnitedHealth buyout offer, scraps Option Care deal

Amedisys Inc on Monday agreed to acquired by UnitedHealth Group for $101 per share in cash, and terminated an all-stock deal to be bought by Option Care Health Inc.

Other symbols: UNH
8 months ago - Reuters

Amedisys agrees to merge with UnitedHealth, and terminates deal with Option Care Health

Amedisys Inc. AMED, -0.15% disclosed Monday that it has agreed to merge with UnitedHealth Group Inc. UNH, -0.43%, and terminated its merger with Option Care Health Inc. OPCH, +1.47% agreed on in early...

Other symbols: UNHOPCH
8 months ago - Market Watch

Amedisys and Optum to Combine, Advancing Value-Based Care for Patients

BATON ROUGE, La., June 26, 2023 (GLOBE NEWSWIRE) -- Amedisys (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care, and Optum, a diversified health services company, have agr...

8 months ago - GlobeNewsWire

Optum Bid for Amedisys Shows Ongoing Reinvention of the Private Healthcare Ecosystem

The growing yet fragmented home health space is moving toward a more consolidated and centralized footing one deal at a time as major players continue snapping up smaller ones, reinventing home health...

Other symbols: UNH
9 months ago - PYMNTS

Optum Offers To Combine With Amedisys, Advancing Value-Based Care for Patients

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Optum offers to combine with Amedisys, a leading provider of home health, hospice and high-acuity care.

Other symbols: UNH
9 months ago - Business Wire

Amedisys received unsolicited buyout bid from Optum that could be ‘superior' to deal with Option Care Health

Amedisys Inc. AMED, +3.64% disclosed Monday that it had received an unsolicited cash buyout bid for $100 a share from Optum, which the at-home healthcare services company believes could be considered ...

Other symbols: OPCHUNH
9 months ago - Market Watch

Amedisys gets over $3 billion unsolicited offer from UnitedHealth's Optum

Amedisys Inc said on Monday it had received an unsolicited proposal from UnitedHealth Group's health services company Optum to acquire all of its outstanding shares in an all-cash transaction worth $3...

Other symbols: UNH
9 months ago - Reuters

Amedisys Announces Receipt of Unsolicited Proposal From Optum

Amedisys Board Determines Optum Proposal Could Reasonably be Expected to Result in a Superior Proposal

Other symbols: OPCH
9 months ago - GlobeNewsWire

AMEDISYS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Amedisys, Inc. - AMED

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Amedisys, Inc. (...

Other symbols: OPCH
10 months ago - Business Wire

ALERT: Rowley Law PLLC is Investigating Proposed Merger of Amedisys, Inc.

NEW YORK , May 4, 2023 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Amedisys, Inc. (NASDAQ: AMED) and its board of directors concerning the proposed merger o...

Other symbols: OPCH
10 months ago - PRNewsWire

Shareholder Alert: Ademi LLP investigates whether Amedisys, Inc. has obtained a Fair Price in its transaction with Option Care Health

MILWAUKEE , May 3, 2023 /PRNewswire/ -- Ademi LLP is investigating Amedisys (NASDAQ: AMED) for possible breaches of fiduciary duty and other violations of law in its transaction with Option Care Healt...

10 months ago - PRNewsWire

AMEDISYS REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS AND UPDATES 2023 GUIDANCE

BATON ROUGE, La. , May 3, 2023 /PRNewswire/ -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period ended March 31, 2023.

10 months ago - PRNewsWire